Host: |
Rabbit |
Applications: |
WB |
Reactivity: |
Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-ARHGAP22 (510-650) is suitable for use in Western Blot research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3. |
Purification: |
Affinity purification |
Dilution Range: |
WB 1:500-1:2000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
ARHGAP22 |
Gene ID: |
58504 |
Uniprot ID: |
RHG22_HUMAN |
Immunogen Region: |
510-650 |
Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 510-650 of human ARHGAP22 (NP_001242953.1). |
Immunogen Sequence: |
NVPAPGLVPGIPSVASMAWS GASSSESSVGGSLSSCTACR ASDSSARSSLHTDWALEPSP LPSSSEDPKSLDLDHSMDEA GAGASNSEPSEPDSPTREHA RRSEALQGLVTELRAELCRQ RTEYERSVKRIEEGSADLRK R |
Function | Rho GTPase-activating protein involved in the signal transduction pathway that regulates endothelial cell capillary tube formation during angiogenesis. Acts as a GTPase activator for the RAC1 by converting it to an inactive GDP-bound state. Inhibits RAC1-dependent lamellipodia formation. May also play a role in transcription regulation via its interaction with VEZF1, by regulating activity of the endothelin-1 (EDN1) promoter. |
Protein Name | Rho Gtpase-Activating Protein 22Rho-Type Gtpase-Activating Protein 22 |
Database Links | Reactome: R-HSA-8980692Reactome: R-HSA-9013148Reactome: R-HSA-9013149 |
Cellular Localisation | CytoplasmNucleusMainly CytoplasmicSome Fraction Is Nuclear |
Alternative Antibody Names | Anti-Rho Gtpase-Activating Protein 22 antibodyAnti-Rho-Type Gtpase-Activating Protein 22 antibodyAnti-ARHGAP22 antibodyAnti-RHOGAP2 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance